Australian Clinical Labs Ltd (AU:ACL) has released an update.
State Street Corporation has emerged as a substantial holder in Australian Clinical Labs Limited, acquiring a 5.18% stake with 10,445,218 ordinary shares. The acquisition, which positions State Street Corporation as a key investor, was finalized on 11th July 2024. Full details of the transaction and the associated entities are outlined in the company’s formal filing.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
